Relevant papers (in PDF form)
======  

[diprate.pdf](diprate.pdf)
------  
Harris LA, Frick PL, Garbett SP et al. An unbiased metric of antiproliferative drug effect in vitro. Nat Methods. 2016; 13(6) 497-500. doi:10.1038/nmeth.3852. PubMed PMID: 27135974. PMCID: PMC4887341.  

[thunor.pdf](thunor.pdf)
------  
Lubbock ALR, Harris LA, Quaranta V, Tyson DR, Lopez CF. Thunor: visualization and analysis of high-throughput dose-response datasets. Nucleic Acids Res. 2021; 49(W1) W633-W640. doi:10.1093/nar/gkab424. PubMed PMID: 34038546. PMCID: PMC8265171.  

[fracprolif.pdf](fracprolif.pdf)
------  
Tyson DR, Garbett SP, Frick PL, Quaranta V. Fractional proliferation: a method to deconvolve cell population dynamics from single-cell data. Nat Methods. 2012; 9 923-928. doi:10.1038/nmeth.2138. PubMed PMID: 22886092. PMCID: PMC3459330.  

[colonyfracprolif.pdf](colonyfracprolif.pdf)
------  

[musyc.pdf](musyc.pdf)
------  
Meyer CT, Wooten DJ, Paudel BB, Bauer J, Hardeman KN, Westover D, Lovly CM, Harris LA, Tyson DR, Quaranta V. Quantifying Drug Combination Synergy along Potency and Efficacy Axes. Cell Syst. 2019 02 27; 8(2) 97-108.e16. doi:10.1016/j.cels.2019.01.003. PubMed PMID: 30797775. PMCID: PMC6675406.  

[growthrate.pdf](growthrate.pdf)
------  
Hafner M, Niepel M, Chung M, Sorger PK. Growth rate inhibition metrics correct for confounders in measuring sensitivity to cancer drugs. Nat Methods. 2016; 13(6) 521-527. doi:10.1038/nmeth.3853. PubMed PMID: 27135972. PMCID: PMC4887336.  

[metrics.pdf](metrics.pdf)
------  
Fallahi-Sichani M, Honarnejad S, Heiser LM, Gray JW, Sorger PK. Metrics other than potency reveal systematic variation in responses to cancer drugs. Nat Chem Biol. 2013; 9(11) 708-714. doi:10.1038/nchembio.1337. PubMed PMID: 24013279. PMCID: PMC3947796.  
